Abstract
Compositions and methods relating to induction of cell death such as in cancer cells are disclosed. Compounds and related methods for synthesis and use thereof, including the use of compounds in therapy for the treatment of cancer and selective induction of apoptosis in cells are disclosed. Compounds in connection with modification of procaspases such as procaspase-3 are disclosed. In various embodiments, the compounds and compositions are capable of activation of procaspase-3.
Original language | English (US) |
---|---|
U.S. patent number | 11612598 |
Filing date | 12/21/18 |
State | Published - Mar 28 2023 |